Table 4.

Indications related to EUS and enteroscopy

Procedural indication	Critical patient-important outcome(s)	Consensus time interval	Consensus reached (%)
27EUS for staging esophageal, gastric or rectal cancer	Avoidance of cancer/cancer progression	Within 1-8 weeks	69.3
28A <2 cm subepithelial esophageal, gastric or duodenal mass	Avoidance of cancer/cancer progression	Defer >8 weeks, and reassess timing	100
29A >2 cm subepithelial esophageal, gastric, or duodenal mass	Avoidance of cancer/cancer progression	Defer >8 weeks, and reassess timing	76.9
30Malignant-appearing solid mass in the pancreas on CT or magnetic resonance imaging∗	Avoidance of cancer/cancer progression	Within 1-8 weeks	83
31Incidentally discovered >2 cm cystic lesion in pancreas on CT or magnetic resonance imaging	Avoidance of cancer/cancer progression	Defer >8 weeks, and reassess timing	84.6
32Incidentally found main pancreatic duct dilation >6 mm on CT scan or magnetic resonance imaging∗	Avoidance of cancer/cancer progression	Defer >8 weeks, and reassess timing	67
33Incidentally found common bile duct dilation >10 mm on CT scan or magnetic resonance imaging	Avoidance of cancer/cancer progression	Defer >8 weeks, and reassess timing	84.6
34Incidentally found pancreatic duct dilation >6 mm and common bile duct dilation >10 mm on CT scan or magnetic resonance imaging (normal results for liver function tests)∗ , †	Avoidance of cancer/cancer progression	No consensus was achieved
35Pancreatic cancer awaiting fiducial placement to start radiation treatment∗	Avoidance of cancer/cancer progression	Within 1-8 weeks	92
36Symptomatic pseudocyst or walled-off necrosis (infection not suspected), for EUS guided drainage	Improvement/ palliation of symptoms; avoidance of major surgery/hospitalization	Within 1-8 weeks	76.9
37Symptomatic pseudocyst or walled-off necrosis (infected suspected), for EUS guided drainage	Avoidance of death/prolongation of life; avoidance of major surgery/hospitalization	Within 1 week	100
38Intractable pancreatic cancer-related abdominal pain, for celiac plexus neurolysis∗	Improvement or palliation of symptoms	Within 1-8 weeks	75
39Idiopathic acute recurrent pancreatitis	Avoidance of major surgery/hospitalization	Defer >8 weeks, and reassess timing	84.6
40High risk for pancreatic cancer undergoing pancreatic cancer screening	Avoidance of cancer/cancer progression	Defer >8 weeks, and reassess timing	100
41Patients with subacute anemia and known small-bowel arteriovenous malformations, for treatment of arteriovenous malformations∗	Avoidance of major surgery and/or hospitalization	Defer >8 weeks, and reassess timing	83

^∗No consensus achieved on the first round of voting.

^†No consensus achieved on the second round of voting.